Full Paper
1
3
1
9
1
5
2
2
H), 7.72 (d, J=9.2 Hz, 2H), 7.26 (d, J=7.4, 4.7 Hz, 1H), 7.06 (d, J=
1H), 6.80 (d, J=8.9 Hz, 2H), 3.00 ppm (s, 6H); C NMR (100 MHz,
CD Cl ): d=151.3, 149.3, 137.9, 130.3, 129.0, 127.2, 120.9, 118.8,
13
.2 Hz, 2H), 3.87 ppm (s, 3H); C NMR (100 MHz, CD Cl ): d=160.6,
2
2
2
2
50.8, 150.1, 149.4, 137.4, 131.1, 123.5, 122.6, 120.8, 120.6, 115.4
116.7, 112.9, 40.8 ppm; HRMS (ESI): m/z calcd for C H N :
16 16 4
264.13695 [M] , 265.14477 [M+H] , 287.12672 [M+Na] ; found:
264.13640 [M] , 265.14382 [M+H] , 287.12537 [M+Na] .
+
+
+
+
6.2 ppm; HRMS (ESI): m/z calcd for C H N O: 252.10056 [M] ,
1
+
4
12
4
+
+
+
+
+
53.10839 [M+H] , 275.09033 [M+Na] ; found: 252.10027 [M] ,
+
+
53.10734 [M+H] , 275.08946 [M+Na] .
PyrTazDMA
DMATazPyr: Starting from 2d (88 mg, 0.85 mmol, 1.00 equiv), 1c
The synthesis of PyrTazDMA was accomplished according to a pub-
(
0
138 mg, 0.85 mmol, 1.00 equiv), CuSO ·5H O (42 mg, 0.17 mmol,
4 2
.20 equiv), and sodium ascorbate (67 mg, 0.34 mmol, 0.40 equiv),
[21]
lished procedure.
Compounds 1d (180 mg, 1.50 mmol,
1
.00 equiv), 2c (240 mg, 1.65 mmol, 1.10 equiv), and Cu(OTf)2
DMATazPyr (121 mg, 54%) was obtained as a yellow solid. M.p.
1
(108 mg, 0.30 mmol, 0.20 equiv) in toluene (6 mL, abs. degassed)
and benzene (11 mg) were heated to reflux for 28 h. The reaction
1
1
1
9
1
4
2
2
50.7–151.58C; H NMR (400 MHz, CD Cl ): d=8.59 (d, J=4.7 Hz,
2 2
H), 8.48 (s, 1H), 8.19 (d, J=8.1 Hz, 1H), 7.80 (dd, J=8.1, 7.4 Hz,
H), 7.62 (d, J=9.4 Hz, 2H), 7.25 (d, J=7.4, 4.7 Hz, 1H), 6.81 (d, J=
mixture was poured on H O and extracted with DCM. Subsequent-
2
13
ly, the combined organic layers were dried over Na SO and con-
.2 Hz, 2H), 3.02 ppm (s, 6H); C NMR (100 MHz, CD Cl ): d=151.3,
2
4
2
2
centrated under reduced pressure. The crude product was purified
51.0, 150.1, 149.1, 137.3, 127.1, 123.3, 122.2, 120.6, 120.5, 112.8,
+
by column chromatography (DCM/Et O, 2%) to yield PyrTazDMA
0.8 ppm; HRMS (ESI): m/z calcd for C H N : 265.13220 [M] ,
2
1
+
5
15
5
1
+
+
(269 mg, 68%) as a yellow solid. M.p. 154.8–156.78C; H NMR
66.14002 [M+H] , 288.12197 [M+Na] ; found: 265.13254 [M] ,
+
+
(400 MHz, CD Cl ): d=8.68 (s, 1H), 8.52 (d, J=4.7 Hz, 1H), 8.20 (d,
66.13866 [M+H] , 288.12122 [M+Na] .
2
2
J=8.2 Hz, 1H), 7.94 (dd, J=8.2, 7.4 Hz, 1H), 7.79 (d, J=9.0 Hz, 2H),
7
6
1
.36 (d, J=7.4, 4.7 Hz, 1H), 6.80 (d, J=9.2 Hz, 2H), 3.00 ppm (s,
BTazPym: Starting from 2e (156 mg, 1.50 mmol, 1.00 equiv), 1a
13
H); C NMR (100 MHz, CD Cl ): d=151.3, 150.0, 149.1, 148.9,
2
2
(
179 mg, 1.50 mmol, 1.00 equiv), CuSO ·5H O (75 mg, 0.30 mmol,
4 2
39.6, 127.2, 123.9, 118.8, 115.6, 114.1, 112.9, 40.8 ppm; HRMS (ESI):
0
.20 equiv), and sodium ascorbate (119 mg, 0.60 mmol, 0.40 equiv),
+
+
m/z calcd for C H N : 265.13220 [M] , 266.14002 [M+H] ,
288.12197 [M+Na] ; found: 265.13243 [M] , 266.13860 [M+H] ,
15
15
5
BTazPym (209 mg, 62%) was obtained as a yellow solid. M.p.
+
+
+
1
1
2
2
50.8–154.28C; H NMR (400 MHz, CD Cl ): d=8.83 (d, J=4.9 Hz,
2 2
+
2
88.12115 [M+Na] .
H), 8.74 (s, 1H), 7.84 (d, J=8.9 Hz, 2H), 7.58 (dd, J=8.9 Hz, 7.4 Hz,
H), 7.50 (t, J=7.4 Hz, 1H), 7.27 ppm (t, J=4.9 Hz, 1H); C NMR
13
(
100 MHz, CD Cl ): d=159.6, 158.1, 148.6, 137.5, 130.4, 129.6, 123.7,
PymTazDMA
2
2
1
21.1, 120.4 ppm; HRMS (ESI): m/z calcd for C H N : 223.08525
12 9 5
The synthesis of PymTazDMA was accomplished according to
+
+
+
[M] , 224.09307 [M+H] , 246.07502 [M+Na] ; found: 223.08420
[21]
a published procedure.
.00 equiv), 2c (208 mg, 1.43 mmol, 1.10 equiv), and Cu(OTf)2
94 mg, 0.26 mmol, 0.20 equiv) in toluene (6 mL, abs. degassed)
Compounds 1e (157 mg, 1.30 mmol,
+
+
+
[M] , 224.09245 [M+H] , 246.07437 [M+Na] .
1
(
AnTazPym: Starting from 2e (141 mg, 1.35 mmol, 1.00 equiv), 1b
and benzene (3 drops) were heated to reflux for 24 h. The reaction
(
201 mg, 1.35 mmol, 1.00 equiv), CuSO ·5H O (67 mg, 0.27 mmol,
4 2
mixture was poured on H O and extracted with DCM. Subsequent-
2
0
.20 equiv), and sodium ascorbate (107 mg, 0.54 mmol, 0.40 equiv),
ly, the combined organic layers were dried over Na SO and con-
2
4
AnTazPym (216 mg, 63%) was obtained as a beige solid. M.p.
centrated under reduced pressure. The crude product was purified
1
1
2
7
62.1–163.48C; H NMR (400 MHz, CD Cl ): d=8.82 (d, J=4.8 Hz,
2 2
by column chromatography (DCM/Et O, 25%) to yield PymTazDMA
2
H), 8.65 (s, 1H), 7.73 (d, J=9.1 Hz, 2H), 7.25 (t, J=4.8 Hz, 1H),
1
(
(
40 mg, 12%) as a yellow solid. M.p. 2128C (dec); H NMR
400 MHz, CD Cl ): d=8.87 (d, J=4.8 Hz, 2H), 8.69 (s, 1H), 7.80 (d,
13
.07 (d, J=9.1 Hz, 2H), 3.87 ppm (s, 3H); C NMR (100 MHz,
2
2
CD Cl ): d=160.7, 159.7, 158.1, 148.3, 130.8, 123.8, 122.7, 120.3,
2
2
J=9.0 Hz, 2H), 7.40 (t, J=4.8 Hz, 1H), 6.81 (d, J=9.0 Hz, 2H),
115.4, 56.2 ppm; HRMS (ESI): m/z calcd for C H N O: 253.09581
13
1
+
3
11
5
3.01 ppm (s, 6H); C NMR (100 MHz, CD Cl ): d=159.8, 155.2,
2
2
+
+
[M] , 254.10364 [M+H] , 276.08558 [M+Na] ; found: 253.09527
1
51.4, 148.9, 127.3, 121.1, 118.3, 117.1, 112.9, 40.7 ppm; HRMS (ESI):
+
+
+
[M] , 254.10248 [M+H] , 276.08474 [M+Na] .
+
+
m/z calcd for C H N : 266.12745 [M] , 267.13527 [M+H] ,
2
289.11658 [M+Na] .
1
4
+
14
6
+
+
89.11722 [M+Na] ; found: 266.12788 [M] , 267.13403 [M+H] ,
+
DMATazPym: Starting from 2e (135 mg, 1.30 mmol, 1.00 equiv), 1c
(
211 mg, 1.30 mmol, 1.00 equiv), CuSO ·5H O (65 mg, 0.26 mmol,
4 2
0
.20 equiv), and sodium ascorbate (103 mg, 0.52 mmol, 0.40 equiv),
General procedure for the Suzuki cross-coupling reactions
DMATazPym (234 mg, 68%) was obtained as a brown solid. M.p.
1
2
2
6
01.8–202.98C; H NMR (400 MHz, CD Cl ): d=8.81 (d, J=4.9 Hz,
Arylbromide (1.00 equiv), 3 (1.00 equiv), K CO (2.50 equiv, 2m de-
2
2
2
3
H), 8.60 (s, 1H), 7.63 (d, J=9.2 Hz, 2H), 7.24 (t, J=4.9 Hz, 1H),
gassed aqueous solution), and [Pd(PPh ) ] (2.5 mol%) were added
3 4
13
.81 (d, J=9.2 Hz, 2H), 3.02 ppm (s, 6H); C NMR (100 MHz,
to degassed THF (50 mm). The mixture was heated to reflux under
an argon atmosphere until full conversion (TLC, ca. 20 h). Subse-
quently, the solvent was evaporated and the residue was dissolved
CD Cl ): d=159.9, 158.0, 151.4, 148.0, 126.9, 123.5, 122.3, 120.2,
2
2
112.7, 40.8 ppm; HRMS (ESI): m/z calcd for C H N : 266.12745
14 14 6
+
+
+
[M] , 267.13527 [M+H] , 289.11722 [M+Na] ; found: 266.12824
in DCM and H O. The aqueous phase was repeatedly extracted
2
+
+
+
[M] , 267.13384 [M+H] , 289.11640 [M+Na] .
with DCM, the combined organic layers were dried over anhydrous
Na SO , and the solvent was removed in vacuo after filtration.
2
4
BTazDMA: Starting from 2c (232 mg, 1.60 mmol, 1.00 equiv), 1a
(
192 mg, 1.60 mmol, 1.00 equiv), CuSO ·5H O (80 mg, 0.32 mmol,
DMABB: Starting from bromobenzene (4a; 196 mg, 1.25 mmol,
4
2
0
.20 equiv), and sodium ascorbate (127 mg, 0.64 mmol, 0.40 equiv),
1.00 equiv), 3 (404 mg, 1.25 mmol, 1.00 equiv), K CO3 (432 mg,
2
BTazDMA (173 mg, 41%) was obtained as a yellow solid after
3.13 mmol, 2.50 equiv, 2m aqueous solution), and [Pd(PPh ) ]
3
4
column chromatography (petroleum ether (PE)/DCM, 1%). M.p.
(36 mg, 31 mmol, 2.5 mol%), DMABB (293 mg, 86%) was obtained
1
1
75.0–176.68C; H NMR (400 MHz, CD Cl ): d=8.11 (s, 1H), 7.81–
as a yellow solid after column chromatography (PE/DCM, 40%).
2
2
1
7
.74 (m, 4H), 7.56 (dd, J=8.6 Hz, 7.4 Hz, 2H), 7.46 (t, J=7.4 Hz,
M.p. 239.8–241.78C; H NMR (400 MHz, CD Cl ): d=7.67–7.65 (m,
2
2
&
&
Chem. Eur. J. 2016, 22, 1 – 13
10
ꢀ 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
ÝÝ These are not the final page numbers!